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Abstract 
Background/Aims: IL10 is a key inhibitor of effector T cell activation and a mediator of intestinal 
homeostasis. In addition, IL10 has emerged as a key immunoregulator during infection with 
various pathogens, ameliorating the excessive T-cell responses that are responsible for much 
of the immunopathology associated with the infection. Because IL10 plays an important role 
in both intestinal homeostasis and infection, we studied the function of IL10 in infection-
associated intestinal inflammation. Methods: Wildtype mice and mice deficient in CD4+ T cell-
derived  or regulatory T cells-derived IL10 were infected with the enteric pathogen Citrobacter 
(C.) rodentium and analyzed for the specific immune response and pathogloy in the colon. 
Results: We found that IL10 expression is upregulated in colonic tissue after infection with C. 
rodentium, especially in CD4+ T cells, macrophages and dendritic cells. Whereas the deletion 
of IL10 in regulatory T cells had no effect on C. rodentium induced colitis, infection of mice 
deficient in CD4+ T cell-derived IL10 exhibited faster clearance of the bacterial burden but 
worse colitis, crypt hyperplasia, and pathology than did WT mice. In addition, the depletion 
of CD4+ T cell-derived IL10 in infected animals was accompanied by an accelerated IFNγ and 
IL17 response in the colon. Conclusion: Thus, we conclude that CD4+ T cell-derived IL10 is 
strongly involved in the control of C. rodentium-induced colitis. Interference with this network 
could have implications for the treatment of infection-associated intestinal inflammation.
Introduction 
Inflammatory bowel diseases (IBDs) are chronic remitting or progressive inflammatory 
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the etiology of these diseases is not fully understood, accumulating evidence indicates 
that the chronic inflammatory responses exhibited by IBD patients occur in genetically 
susceptible persons after abnormal exposure of the mucosal immune system to enteric 
bacteria [1, 2]. However, both the virulence mechanisms by which bacterial pathogens 
colonize the intestinal tract of their hosts and the specific host responses that defend 
against such infections are poorly understood. Therefore, models of infectious colitis are 
crucial for defining the potentially pathogenic host responses to enteric bacteria. Infection 
with Citrobacter (C.) rodentium, a noninvasive mouse pathogen that belongs to the group 
of attaching and effacing bacteria, is one of the few available models of infectious colitis [3, 
4]. In addition to producing the typical signs of bacterially induced inflammation, including 
crypt hyperplasia and thickening of the mucosa, infection with C. rodentium causes robust 
TH1 and TH17 responses in C57BL/6 mice [5-8]. Cells of the adaptive immune system, such 
as CD4+ T cells and B cells, contribute to protection against C. rodentium infection and mice 
depleted of either cell type have an impaired ability to clear the infection [9-12]. Therefore, 
the immune response is crucially involved in the clearance of C. rodentium and in limiting 
inflammatory damage, but little is known about the mechanisms or molecules involved. 
One of the key molecules participating in immunomodulation and regulation of intestinal 
homeostasis is IL10. The association between IL10 and intestinal homeostasis became clear 
with the discovery that intestinal inflammation develops spontaneously in mice deficient in 
IL10 and IL10 receptor (IL10R) with age [13, 14]. Similarly, severe enterocolitis develops 
within the first months of life in infants with deleterious mutations in IL10, IL10RA, or 
IL10RB [15]. However, although the therapeutic potential of IL10 has been investigated 
in animal models and in IBD patients [16, 17], its administration has not been associated 
with a beneficial response during inflammation [18]. In addition to its fundamental function 
during intestinal homeostasis, IL10 also plays a crucial role during infection. IL10 regulates 
the immune responses induced by various pathogens and their products, thereby preventing 
damage to host tissues [13]. However, with some infections IL10 impedes the ability of the 
host immune response to eliminate the pathogen, thereby contributing to chronic infection 
[19-21]. In contrast the ablation of IL10 signaling during infection increases pathogen 
clearance but is accompanied by an exaggerated immunopathology [21-23]. These effects 
demonstrate the dichotomy of IL10 activity during infection. 
Because IL10 plays a substantial role in intestinal homeostasis and infection, the aim 
of the present study was to elucidate the relative importance of IL10 in the control of CD4+ 
T cell responses during C. rodentium-associated colitis. Understanding the mechanisms that 
contribute to the resolution of bacterially induced inflammation would support the design of 
new strategies for immune intervention.
Materials and Methods
Mice
All animals used in this study were 8- to 12-week-old, bred and housed under specific pathogen-
free conditions in the Laboratory Animal Facility of the University Hospital Essen. WT BALB/c mice were 
obtained from Harlan Winkelmann GmbH (Borchen, Germany) or bred in house. IL-10flox/flox mice, CD4Cre 
(BALB/c), and FIC mice (expressing Cre under the control of the forkhead box P3 [Foxp3] promoter) were 
established as described [24, 25]. Crossing CD4-Cre or FIC-Cre mice with IL-10flox/flox mice resulted in mice 
specifically deficient in IL-10 in either CD4+ cells (termed CD4-IL10ko mice) or CD4+FoxP3+ T cells (termed 
FoxP3-IL10ko mice). IL-10/eGFP knock-in tiger mice (termed IL10-GFP mice), which express both IL-10 
and GFP under the endogenous regulatory sequence of the IL-10 locus, were generated as described [26]. 
All mice used were generated on the BALB/c background. CD4-IL10ko mice, FoxP3-IL10ko mice, and IL10-
GFP mice were subjected to the C. rodentium infection protocol.
All animal experiments were performed in strict accordance with the guidelines of the German Animal 
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C. rodentium infection model 
The nalidixic acid–resistant C. rodentium strain ICC169 used in this study shows the same infectivity 
as the WT strain ICC168 [27]. C. rodentium were cultured overnight in Luria-Bertani at 37°C, centrifuged 
at 3000×g for 10 min, and washed with PBS. Mice were infected by oral gavage with 200 µl PBS containing 
approximately 2×109 CFUs of C. rodentium. After gavage, an aliquot of the remaining suspension was 
plated in serial dilutions on MacConkey agar to control the infective dose. Bacterial numbers in stool 
were determined by collecting fecal pellets at various time points after infection, weighing them, and 
homogenizing them in 1 ml of PBS. Serial dilutions of the homogenates were plated on MacConkey agar, and 
the numbers of CFUs were determined after overnight incubation at 37°C. Mice were analyzed at various 
time points after infection (p.i.), and the spleens, mesenteric lymph nodes (MLNs), and colon were removed 
and prepared for analysis as described below. Spleen weight was determined after the spleen was removed. 
Isolation of splenocytes and mesenteric lymph node cells
Spleens were rinsed with an erythrocyte lysis buffer (containing 0.15 M NH4Cl, 10 mM KHCO3, and 
0.5 M EDTA), meshed through a 100-µ cell strainer, and washed with PBS containing 2 mM EDTA and 2% 
fetal calf serum. Mesenteric lymph nodes were meshed through a 100-µ cell strainer and washed with PBS 
containing 2 mM EDTA and 2% FCS.
Isolation of lamina propria lymphocytes from the colon
Lamina propria (LP) lymphocytes were isolated as described previously [28], with minor modifications. 
Colons were flushed with PBS to remove feces, opened longitudinally, and cut into 1-cm pieces. Tissue 
pieces were washed twice in PBS containing 3 mM EDTA for 10 min at 37°C with rotation. EDTA was 
removed by washing colon pieces twice in Roswell Park Memorial Institute (RPMI) medium containing 1% 
FCS, 1 mM EGTA, and 1.5 mM MgCl
2
 for 15 min at 37°C with rotation. Colon pieces were then subjected to 
intense vortexing, washed with PBS, and digested in RPMI containing 20% FCS and 100 U/mL collagenase 
(Clostridium histolyticum; Sigma-Aldrich, St. Louis, MO) for 90 min at 37°C. Remaining tissue was separated 
from cells by passing the cell suspension through a 40-µ cell strainer and washing it with culture medium.
Macroscopic and histopathologic assessment of colitis  
Macroscopic colonic damage was assessed on the day of euthanasia. Assessment was based on 
two main characteristics of the pathologic state: colon length shortening and colon weight gain. We then 
determined the colon weight-to-length ratio, which is considered to be a reliable and sensitive indicator of 
the severity and extent of the inflammatory response in colitis [29]. 
Colons were prepared as Swiss rolls, and stored in 4% paraformaldehyde until the tissue was embedded 
in paraffin for histologic scoring. Tissue sections (4 µm) were prepared from paraffin-embedded tissue 
blocks, H&E stained and evaluated histopathologically in a blinded manner. The colon was divided into 3 
equal portions (oral, middle, and rectal) and assessed for inflammatory cell infiltrates, epithelial damage, 
goblet cell depletion, neutrophil infiltration, crypt abscesses, and crypt hyperplasia, each in a 0 to 3 scoring 
system (0=no change; 1=mild change; 2=moderate change; 3=profound change) (Klopfleisch, 2013). All 
evaluated parameters together gave rise to an overall inflammatory score (0-54) for oral (0-18), middle (0-
18), and rectal (0-18) colon regions. Crypt heights were measured by micrometry; 30 measurements were 
taken in the distal colon for each mouse. Only well-oriented crypts were measured. 
Antibodies and flow cytometry
Splenocytes, MLN cells, and LP lymphocytes were stained with fluorochrome-labeled anti-mouse CD4 
(RM4-5), CD8 (53-6.7), CD11c (HL3), CD45 (30-F11), CD25 (7D4), F4/80 (BM8), I-A/I-E (M5/114.15.2), 
CD19 (1D3), B220 (RA3-6B2) and CD69 (H1.2F3) antibodies. All antibodies used in this study were obtained 
from either BD Biosciences (Heidelberg, Germany) or eBioscience (Frankfurt, Germany). For analysis of 
intracellular cytokines, lymphocytes (0.5×106 cells per well) isolated from spleens, MLNs, and LPLs were 
stimulated for 4-h with 10 ng/mL PMA and 1 µg/mL ionomycin in the presence of 5 µg/mL Brefeldin A (all 
from Sigma-Aldrich) or 5µg/ml Monensin (e-bioscience). After staining cell surface antigens, the cells were 
fixed with 2% paraformaldehyde, permeabilized with 0.1% NP-40, and stained for intracellular cytokines 
(anti-IL-17A [TC11-18H10.1], anti-IFN-γ [XMG1.2], anti-IL10 [JES5-16E3] and anti-IL22 [Poly5164] 
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(145-2C11) antibody before intracellular cytokine staining. Cells were analyzed by flow cytometry on an 
LSR II instrument using DIVA software (BD Biosciences).
Cytokine detection 
Spleen and MLN cells were isolated and stimulated with anti-CD3 antibody as described. The levels of 
IFN-γ and IL-17 in cell culture supernatants were quantified with the Procarta Cytokine assay kit (Panomics, 
Fremont, CA) according to the manufacturer’s recommendations. The assay was performed on a Luminex 
200 instrument, and levels of cytokines were calculated with the Luminex IS software (Luminex Corporation, 
Austin, TX).
Quantitative reverse transcriptase PCR
RNA was obtained from distal colon biopsy samples with the RNeasy Fibrous Tissue Kit (Qiagen). After 
DNase digestion (Qiagen), cDNA was synthesized with M-MLV Reverse Transcriptase (Promega, Mannheim, 
Germany) and Oligo-dT mixed with Random Hexamer primers (Invitrogen, Karlsruhe, Germany) on an 
ABI PRISM cycler (Applied Biosystems, Life Technologies, Darmstadt, Germany). Real-time RT-PCR was 
performed with the SYBR Green PCR kit and specific primers for IL-10 (5′-CTG GAC AAC ATA CTG CTA ACC 
GAC TC-3′ and 5′-ATT TCT GGG CCA TGC TTC TCT GC-3′), IL10Rα (5’- TCA TGG TGA CAT TCC AGG GC -3’ and 
5’- TGG AGG CCA AGC CAA ATC AT -3’), IL-17 (5′- GCT CCA GAA GGC CCT CAG ACT ACC-3′ and 5′-TTC CCT 
CCG CAT TGA CAC AGC-3’), IFNγ (5’- AGG AAC TGG CAA AAG GAT GGT GA-3’ and 5’- TGT TGC TGA TGG CCT 
GAT TGT CTT -3’), IL-22 (5’- CTC CCC CAG TCA GAC AGG TTC C -3’ and 5’- ACA GCA GGT CCA GTT CCC CAA TC 
-3’), IL-1β (5′-ACT ACA GGC TCC GAG ATG AAC AAC-3′ and 5′-CCC AAG GCC ACA GGT ATT TT-3′), FoxP3 (5′-
CTG GCG AAG GGC TCG GTA GTC CT-3′ and 5′-CTC CCA GAG CCC ATG GCA GAA GT-3′), and ribosomal protein 
S9 (RPS9) (5′-CTG GAC GAG GGC AAG ATG AAG C-3′ and 5′-TGA CGT TGG CGG ATG AGC ACA-3′). Relative RNA 
levels were determined with included standard curves for each individual gene and further normalization 
to the housekeeping gene RPS9.
TH1 and TH17 cell-polarization 
CD4+ CD25- T cells were FACS-sorted and activated in vitro with plate-bound α-CD3 (TH1: 5 µg/
ml, TH17: 0.75µg/ml) and soluble α-CD28 (TH1 and TH17: 1 µg/ml) (both BD Bioscience). For TH1 
polarization cultures contained recombinant IL12 (20ng/ml) (R&D Systems) and anti-IL4 antibody (200 
ng/ml) (eBioscience). For TH17 polarization media were supplemented with recombinant TGFβ (2ng/ml), 
IL21 (100ng/ml), IL23 (20ng/ml) (all R&D Systems, Wiesbaden, Germany), IL1β (20ng/ml) (eBioscience), 
IL6 (50ng/ml) (PreproTech), α-IL4 (200ng/ml), αIFNγ (200ng/ml) and αIL2 (200ng/ml) (eBioscience) 
antibodies. Where indicated, recombinant IL10 (250ng/ml) (eBioscience) or anti-IL10 antibody (5µg/ml) 
(BioXCell) was added. 
Statistical analysis
All results were expressed as mean ± SEM. Differences were assessed by Student’s t-tests, One-Way 
ANOVA or Mann Whitney t-tests. Data analysis was performed with Prism 5.0 software (GraphPad, La Jolla, 
CA). Statistical significance was set at the level of P<0.05.
Results 
C. rodentium infection in BALB/c mice induces IL10 expression in colonic tissue
The appropriate temporal and spatial expression of IL10 is believed to play a key role 
in sustaining the balance between inflammation and immunoregulation. Especially in the 
gut, IL10 is described as a mediator of intestinal homeostasis, but little is known about the 
function of IL10 during bacterially induced colitis. To assess the expression of IL10 during the 
course of intestinal infection, WT BALB/c mice were infected with C. rodentium and analyzed 
at several time points post infection. Quantification of the C. rodentium load in fecal samples 
from infected mice showed detectable C. rodentium colonization at day 3 post-infection (p.i.), 
maximal burden with 108 CFUs/g of feces between days 7 and 14 p.i., and bacterial clearance 
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after infection (Fig. 1B). Quantitative PCR analysis of colonic IL10 mRNA showed a transient 
response, with a significant increase (3- to 4-fold) on days 7 and 10 after infection, followed 
by a reduction to control levels at day 21 (Fig. 1C). Therefore, there is an association between 
maximal IL10 expression and maximal C. rodentium burden on day 10 post-infection (Fig. 
1A and 1C). To define the cellular source of IL10 production during C. rodentium infection, 
we infected IL10-GFP reporter mice (1D) or BALB/c mice (1E-F) with C. rodentium and used 
Fig. 1. Citrobacter ro-
dentium infection in-
duces production of 
colonic IL10. BALB/c 
mice were infected 
with C. rodentium 
(CR) or given ve-
hicle control (PBS) 
by orogastric gavage 
(A-C). At various time 
points post infection 
(days post-infection, 
dpi) CR burdens in fe-
cal samples (n=9) (A) 
and the inflamma-
tory score (n=3) in 
oral (O), middle (M), 
and rectal (R) colon 
regions (B) were 
determined. IL10 
mRNA expression in 
rectal colon tissue bi-
opsy samples (n=5) 
was quantified at in-
dicated time points 
by real-time PCR (C). 
Gene expression was 
normalized to the ex-
pression of ribosom-
al protein S9 (RPS9) 
and is shown as fold 
change in induction 
over naïve tissues 
(C). FACS analysis of 
IL10 expression by 
CD4+ T cells (gated 
on CD4+) (D), mac-
rophages (gated 
on F4/80+/CD11c- 
of CD45+MHCII+ ) 
(E) and dendritic 
cells (gated on 
F4/80-/CD11c+ of 
CD45+MHCII+) (F) in 
spleen, MLNs and LPLs of CR-infected or PBS-treated IL10-GFP reporter mice (n=7-9) (D) or BALB/c mice 
(n=8-11) (E-F) was performed on day 10 after infection. Data shown in the graphs are given as mean ± SEM. 



















   
   
   
   
   
   
   
   
   



















Cell Physiol Biochem 2015;36:1259-1273
DOI: 10.1159/000430295
Published online: July 01, 2015
© 2015 S. Karger AG, Basel
www.karger.com/cpb 1264
Seiffart et al: IL10 Deficiency Exacerbates Bacteria Induced Colitis
Cellular Physiology 
and Biochemistry
flow cytometry to examine cells from the spleen, MLNs, and colonic lamina propria (LP) 
on day 10 after infection. We found that LP CD4+ T cells, macrophages, and dendritic cells 
(DCs) exhibit a significant increase in IL10 expression after C. rodentium infection (Fig. 1D-
F). However, C. rodentium infection does not induce IL-10 in CD8+ T cells and CD19+B220+ B 
cells (data not shown). To further define the inflammatory response of BALB/c mice after C. 
rodentium infection LP CD4+ T cells were characterized by flow cytometry for the expression 
of IFNγ, IL17 and TH17-associated IL22. As expected, the percentage of CD4+IL17-, and 
CD4+IL22-producing T cells increased on days 3 to 10 after infection and reduced to control 
levels at day 21 (Fig. 2A and C). However, there was no enhancement in the percentage of 
CD4+IFNγ-producing TH1 cells (Fig. 2B) suggesting a difference in the immune response 
against C. rodentium infection in BALB/c mice and C57BL/6 mice.
Taken together, these results show that IL10 production is significantly increased in 
colonic tissue after C. rodentium infection and that this increase is correlated with effector 
cytokine production and disease progression. 
Treg-derived IL10 is not sufficient to alter C. rodentium-induced colitis
IL10 is produced by several CD4+ T-cell subsets, such as regulatory T cells (Tregs) or TH2 
cells. Especially in the intestine, FoxP3+ Tregs play a central role in the control of immune 
responses. Our results are consistent with this knowledge: biopsy of the distal colon showed 
that on day 10 after infection FoxP3 expression was significantly higher in C. rodentium-
infected mice than in PBS-treated control mice (Fig. 3A). In addition, the expression of IL10 
was enhanced in colonic Tregs in C. rodentium-infected mice (Fig. 3B). To determine whether 
Fig. 2. Influence of C. rodentium infection on 
IL17, IFNγ and IL22 effector cytokine expres-
sion by CD4+ T cells. BALB/c mice (n=3-4/time 
point) were infected with C. rodentium (CR) or 
given vehicel control (PBS) by orogastric gavage 
(A-C). At various time points post infection (days 
post-infection, dpi) splenocytes, MLNs and LPLs 
were analyzed by fluorescence-activated cell 
sorting (FACS) for IL17 (A), IFNγ (B) and IL22 
(C) effector cytokine expression by CD4+ T cells. 
Data shown in the graphs are given as mean ± 
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regulatory T cell-derived IL10 plays a role in C. rodentium-induced colitis, we infected 
IL10flox/flox x Fox-IRES-Cre  (FIC) mice (referred to as FoxP3-IL10ko) mice, which display a 
specific depletion of IL10 in FoxP3+ Tregs, and littermate control mice with C. rodentium. 
Surprisingly, we found no significant differences in bacterial load (Fig. 3C), spleen weight 
(Fig. 3D), colon weight-to-length ratio (Fig. 3E), crypt length (Fig. 3F) or inflammatory score 
(Fig. 3G) between the two types of mice. This finding indicates that the absence of Foxp3+ 
Treg-derived IL10 alone is not sufficient to alter C. rodentium-induced pathology. Therefore, 
IL10 production by Foxp3+ regulatory T cells appears to be a negligible factor in controlling 
C. rodentium-associated colitis.
CD4+ T cell-derived IL10 controls the immunopathology of C. rodentium-induced 
inflammation
To further elucidate the physiologic effect of CD4+ T cell-derived IL10 on the intestinal 
inflammation associated with C. rodentium infection and on bacterial clearance, we used 
mice with a specific depletion of IL10 in all CD4+ T cells (IL10flox/flox x CD4-Cre, referred to as 
CD4-IL10ko mice). We infected these mice and WT littermate control mice with C. rodentium 
and analyzed at day 10 after infection, a time point at which bacterial burden, intestinal 
inflammation, and IL10 expression by CD4+ T cells are highest (Fig. 1). Determination of 
the bacterial burden in the feces during the course of infection showed that bacterial loads 
were similar in both types of mice on day 3 after infection. However, mice deficient in IL10-
producing CD4+ T cells exhibited enhanced control of the infection at day 7 and significantly 
lower bacterial numbers at day 10 than did infected WT mice (Fig. 4A). Interestingly, 
Fig. 3. Influence of Treg-derived 
IL10 on C. rodentium-induced colitis. 
BALB/c mice were infected with CR 
(n=4) or treated with PBS (n=5) by 
orogastric gavage. On day 10 post-
infection FoxP3 mRNA expression in 
rectal colon tissue biopsy samples 
was determined. Gene expression 
was normalized to the expression 
of RPS9 and is shown as fold change 
(A). FACS analysis of IL10 expres-
sion by CD4+CD25hi T cells in spleen, 
MLNs and LPLs of CR-infected (n=9) 
or PBS-treated (n=7) IL10-GFP re-
porter mice was performed on day 
10 after infection (B). FoxP3-IL10ko 
mice (n=8) or control littermates 
(WT, n=6) were orally infected 
with CR. Bacterial burdens in fe-
cal pellets were quantified at the 
time points indicated (C). On day 
10 post-infection spleen weight (D) 
and colon weight-to-length ratio (E) 
were measured, rectal crypt length 
(F) was determined by micrometry, 
and rectal inflammatory score (G) 
was determined by histologic analy-
sis. Data shown in the graphs are 
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accelerated bacterial eradication in CD4-IL10ko mice was associated with exaggerated 
inflammation, characterized phenotypically by significantly higher spleen weight (Fig. 4B) 
and significantly larger colon weight-to-length ratio (Fig. 4C) than in infected WT mice. In 
addition, histologic analysis of the colon showed that C. rodentium-infected CD4-IL10ko 
mice exhibited severer crypt elongation and crypt hyperplasia (Fig. 4D-F) and a higher 
inflammation score than did control mice (Fig. 4G). These findings suggest that the presence 
Fig. 4. Influence of CD4+ T cell-derived IL10 on C. rodentium-induced colitis. CD4-IL10ko mice or control 
littermates (WT) were infected with CR or given PBS by orogastric gavage. CR burdens in fecal pellets har-
vested from infected WT or CD4-IL10ko mice were analyzed throughout the course of infection (A). Spleen 
weight (B) and colon weight-to-length ratio (C) were determined on day 10 post-infection. (A-C: WT n=12, 
CD4-IL10ko n=12). Histologic examination of infection-induced inflammation in H&E-stained sections of 
oral (O), middle (M), and rectal (R) colon regions was performed on day 10 after infection (D-G). Represen-
tative H&E-stained sections from M and R colon regions of CR-infected or PBS-treated WT or CD4-IL10ko 
mice are shown in D. Scale bars represent 100-µm increments, and black bars indicate crypt length. Sections 
were semiquantitiatively scored (0-3) and  measured for rectal crypt length (in µm) (E) and crypt hyper-
plasia (F) and overall inflammatory parameters (G) were quantified in O, M, and R colon regions. (E-G: WT 
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of CD4+ T cell-derived IL10 is important not for the eradication of C. rodentium but rather for 
the control of infection-associated inflammation.
IL10 deficiency in CD4+ T cells enhances the C. rodentium-induced IL17 response and 
facilitates an IFNγ response in the colon
To assess the effects of IL10-producing CD4+ T cells on effector T cells during C. 
rodentium infection, we isolated lymphocytes from the spleen and the MLNs of C. rodentium-
infected CD4-IL10ko mice and WT mice on day 10 after infection and used flow cytometry 
Fig. 5. CD4+ T cell-derived IL10 controls C. rodentium-induced IL17 responses. CD4-IL10ko mice (n=10) 
or control littermates (WT, n=10) were orally infected with CR or given PBS by orogastric gavage and were 
analyzed on day 10 post-infection. Splenocytes and cells from MLNs were analyzed by FACS for CD69 (A) 
expression (gated on CD4+ T-cells). After ex vivo stimulation of isolated splenocytes and MLN cells with anti-
CD3 mAb for 72 h,  TH17 (B), and TH1 (C) cell responses were measured by FACS (gated on CD4+ T cells). 
Cell culture supernatants from anti-CD3 mAb-stimulated splenocytes and MLNs were recovered for mea-
surement of IL17 (B) and IFNγ (C) levels by Luminex. Data shown in the graphs are given as mean ± SEM. *, 



















   
   
   
   
   
   
   
   
   



















Cell Physiol Biochem 2015;36:1259-1273
DOI: 10.1159/000430295
Published online: July 01, 2015
© 2015 S. Karger AG, Basel
www.karger.com/cpb 1268
Seiffart et al: IL10 Deficiency Exacerbates Bacteria Induced Colitis
Cellular Physiology 
and Biochemistry
to analyze them phenotypically. The expression of the early activation marker CD69 by CD4+ 
T cells in the spleen and in MLNs was significantly upregulated in CD4-IL10ko mice but not 
in infected WT mice (Fig. 5A), a finding demonstrating the exaggerated activation status of 
these cells. Because C. rodentium infection of BALB/c mice is characterized by elevated TH17 
responses, we determined the percentage of IL17-producing CD4+ T cells in spleens and 
MLNs from infected CD4-IL10ko mice and WT mice. We found that IL10 depletion in CD4+ 
T cells significantly increased the percentage of IL17-producing T cells and IL17 secretion 
after in vitro stimulation of lymphocytes isolated from infected CD4-IL10ko mice (Fig. 
5B).  Consequently, quantitative PCR analysis of colonic biopsy samples showed increased 
expression of IL17, IL22, and IL1β in CD4-IL10ko mice (Fig 6A,C and D). The percentage of 
IFNγ-producing CD4+ T cells and IFNγ-secretion was not altered in the spleens and MLN of 
infected mice (Fig. 5C) but significantly increased in the colon of C. rodentium infected CD4-
IL10ko mice (Fig. 6B). These results suggest that IL10 significantly contributes to the control 
of C. rodentium-induced colitis. 
 
IL10 does not directly alter IL17 expression in vitro
In order to understand the immunoregulatory mechanism of IL10 on TH1 and TH17 
cells, we first analyzed whether TH1 and TH17 cells express the IL10 receptor (IL10R), 
and could therefore respond to IL10 directly. We included in vitro polarized TH1 and TH17 
cells, naïve CD4+ T cells and Tregs, known to express high levels of IL10R [30]. Interestingly, 
the expression of IL10R was strongly downregulated on in vitro polarized TH1 and TH17 
cells compared to naïve CD4+ T cells and Tregs (Fig. 7A), a finding suggesting that IL10 
may not directly act on activated polarized TH1 and TH17 cells. To examine whether IL10 
may influence the differentiation of TH cells we performed polarization experiments in the 
Fig. 6. CD4+ T cell-derived IL10 controls IL17 and IFNγ production in colonic tissues after C. rodentium in-
fection. CD4-IL10ko mice (n=6) or control littermates (WT, n=6) were orally infected with CR and analyzed 
on day 10 post-infection (p.i.). Biopsy samples from rectal colon tissue were analyzed by real-time PCR for 
IL17 (A) IFNγ (B), IL22 (C) and IL-1β (D) mRNA expression. Gene expression was normalized to the RPS9 
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presence and absence of recombinant IL10 or anti-IL10 antibodies. Of note, the presence or 
absence of IL10 during polarization does not alter the IL17 response on mRNA level and on 
protein level indicating that IL10 may act indirectly on TH17 (Fig. 7B and C). 
Discussion 
The results of this study show that CD4+ T cell-derived IL10 is involved in the control of 
C. rodentium-induced colitis in BALB/c mice. IL10 expression was upregulated in CD4+ T cells 
from the colonic tissue of mice infected with C. rodentium. Infected mice, deficient in CD4+ T 
cell-derived IL10 exhibited faster clearance of the bacterial burden but experienced worse 
colitis, crypt hyperplasia, and pathology than did WT mice. Importantly, the depletion of 
CD4+ T cell-derived IL10 was accompanied by an accelerated colonic IFNγ and IL17 response 
in infected animals. 
IL10 is produced by many cell types, including T cells, B cells, and most myeloid-
lineage cells [31]. It also acts on a variety of immune cells, controlling the activity of effector 
T cells [32], NK cells [33], and APCs [34, 35]. IL10 is an important mediator of intestinal 
homeostasis [36] and has emerged as a key immunoregulator during infection with various 
pathogens, ameliorating the excessive T-cell responses that are responsible for much of the 
immunopathology associated with these infections [37]. After C. rodentium infection, CD4+ T 
cells, including regulatory and effector T cells, exhibit increased production of IL10, although 
Fig. 7. IL10 does not influence in vitro 
polarization of TH17 cells. CD4+ CD25- 
T cells or CD4+CD25hi Tregs were FACS 
sorted from spleens of BALB/c mice. 
CD4+ CD25- T cells were either left un-
treated (naïve) or were polarized un-
der TH1 and TH17 cell conditions for 
3 days. Relative expression of IL10 re-
ceptor (IL10R) was analyzed by real-
time PCR. Gene expression was nor-
malized and is shown as fold change 
over naïve. Data shown in the graphs 
are given as mean ± SEM.  The results 
are summarized from two indepen-
dent experiments. (A). Sorted CD4+ 
CD25- T cells were either left untreat-
ed (naïve) or were polarized under 
TH17  cell conditions in the presence 
of recombinant IL10 (rmIL10, 250ng/
ml) or a neutralizing IL10 antibody 
(αIL10, 10µg/ml). Relative expres-
sion of IL17 was analyzed by real-time 
PCR. Gene expression was normal-
ized and is shown as fold change over 
naïve. Data shown in the graphs are 
given as mean ± SEM. The results are 
summarized from two independent 
experiments (B). Sorted CD4+ CD25- T 
cells were either left untreated (naïve) 
or were polarized under TH17 cell conditions in the presence of recombinant IL10 (rmIL10, 250ng/ml) or a 
neutralizing IL10 antibody (αIL10, 10µg/ml). IL-17 expression was determined by intracellular FACS stain-
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the relative importance of each of these T-cell types is debated and may change during the 
infection process. However, we found that the depletion of IL10 from FoxP3+ regulatory T 
cells did not alter bacterial eradication or affect the development of C. rodentium-associated 
colitis. In contrast, C. rodentium infection of mice with IL10 deficiency in all CD4+ T cells 
resulted in faster bacterial clearance but severer inflammation of the colon. 
Several mechanisms that control the immune responses have been described. In C. 
rodentium infection of C57BL/6 mice, overproduction of both TH1-derived IFNγ and TH17-
derived IL17 mediates the pathology [8, 38]. Importantly, we show that the infection of 
WT BALB/c mice with C. rodentium leads to an enhanced TH17 response in the colon but 
no alteration in the TH1 response was detectable, showing that the genetic background 
significantly defines the susceptibility and the immune response to infection. However, 
after depletion of IL10 in CD4+ T cells we detected a significant increase in IFNγ-, IL17-, and 
IL22-expression in the colon of infected CD4-IL10ko mice compared to infected WT mice. 
Interestingly, in vitro and in vivo studies have demonstrated that IL10 can control both TH1 
and TH17 immune responses [39, 40]. In particular, IL10 inhibits the differentiation and 
proliferation of TH1 cells by selectively inhibiting the function of APCs [34, 35, 41]. This is 
well in line with our data, as we showed that polarized TH1 cells express low levels of IL10R. 
Huber and colleagues demonstrated that ex vivo freshly isolated TH17 CD4+ T cells express 
IL10R [42]; this expression makes them sensitive to IL10, and IL10 sensitivity in turn leads 
to the inhibition of TH17 effector functions [30]. However, in the present study we detected 
that in vitro polarized, recently activated TH17 down-regulate IL10R expression. In addition, 
the in vitro differentiation of TH17 cells seems not be influenced by IL10 as polarization of 
TH17 T cells in the presence of IL10 in vitro was not altered. These results imply that IL10 
may also act indirectly on the differentiation by selectively inhibiting the function of APCs 
which is in accordance with a study by Gu et al. [43], showing that APCs contribute to the 
negative regulation of TH17 cell differentiation by IL10. However, our data do not exclude 
a possible further direct contribution of IL10 on T cells in vivo as it was described by Huber 
et al. [42].
The differentiation and maintenance of TH17 cells depend on a specific combination of 
cytokines, including TGF-β, IL-6, IL-23, and IL1β [44-46]. In the present study we found an 
increase in IL1β expression. IL1β is a proinflammatory cytokine that is produced after pattern 
recognition receptors are activated by microbial products; IL1β induces the recruitment 
of neutrophils and macrophages and activates the release of other cytokines important to 
host defense. Chung and colleagues demonstrated that IL1β signaling drives an early TH17 
differentiation [47]. In addition it was shown that balanced IL1β activity is required for the 
host response to C. rodentium infection as IL1β improved the bacterial clearance but also 
increased tissue damage [48]. These results are in accordance with those of our study as we 
found that increased expression of IL17 and IL22 in the colon of C. rodentium-infected CD4-
IL10ko mice was accompanied by elevated IL1β expression. 
Taken together, this study indicates that bacterial eradication requires a coordinated 
response in which initial proinflammatory mechanisms clear the pathogen and are then 
down-regulated by IL10 before pathology occurs. Thus, both the timing and the relative 
amounts of proinflammatory and antiinflammatory cytokine production are crucial for safe 
clearance of the bacterial burden. Therapeutic strategies augmenting IL10 to reduce host 
injury during infection must therefore be combined with effective antimicrobial agents to 
ensure the safe elimination of the pathogen.
Abbreviations 
CR (Citrobacter rodentium); dpi (days post-infection); FIC (Fox-IRES-Cre); IBD 
(inflammatory bowel disease); LP (lamina propria); LPL (lamina propria lymphocytes); p.i. 
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